Magnifying Glass

Showing 2 results for “Spencer Sherman | Expert Analysis”

Search Results

Genetic Testing and Risk Assessments for Opioid Use Disorder (OUD)

By: Spencer Sherman, Pharm.D., Clinical Pharmacist, Enlyte Pharmacy Solutions On December 19, 2023, the U.S. Food and Drug Administration (FDA) approved the first test (AvertD) that uses DNA in assessing whether certain individuals may have an elevated […]

Emerging Opioid Overdose Reversal Medications

Author: Spencer Sherman, Pharm.D., Clinical Pharmacist, Enlyte Opioids continue to represent a decreasing portion of overall workers’ compensation prescriptions, with favorable trends being seen in markers such as dose and duration of use. Despite declines, […]